Using hair follicle secretome to improve recovery after aesthetic procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather real-world data on the application of an autologous hair follicle derived secretome topical product following various medical aesthetic procedures. Participants will include individuals planning to undergo such procedures and who intend to use the secretome product. The study will track outcomes related to post procedural erythema and overall recovery. It is designed to be non-interventional, meaning that it will observe the effects of the product without altering the standard care provided to participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male and Female
* Ages: 18-60
* Any Fitzpatrick skin type
* Planning a medical aesthetic procedure
* For subjects receiving hair procedures (closed to enrollment):

  1. Androgenic alopecia
  2. Traction alopecia
  3. Scarring alopecia
  4. Stable use of any medication or supplement for hair loss, including finasteride, any other 5 α-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to enrollment in the study is allowed.
  5. No intention to start new hair growth medications or change dose of hair growth medications from the time of consent through the end of the study follow-up period.
* Undergoing one of the following medical aesthetic procedures:

  1. Laser resurfacing of the face (ablative or non-ablative) or Ellacor of the face (Ellacor closed to enrollment)
  2. Tixel of the face
  3. Keralase of the scalp (scalp treatment closed to enrollment)
  4. Acne Scars and Surgery scars, either old or new as long as old scars are also being treated with ablative or non-ablative laser or microneedling (e.g. abdominoplasty, breast reduction/ reconstruction/enhancement, post-weight loss, etc.
* Planning to use Acorn Autologous Hair Follicle Secretome cosmetic product

Exclusion Criteria:

* Pregnant or Breastfeeding
* Participation in an interventional clinical trial in the last 30 days
* Use of other topical cosmetic products that may confound results
* Use of retinoids within 7 days prior to facial procedure
* For those receiving hair treatment, must not have had a hair transplant in the treatment area within the past 12 months
* Any health condition that in the investigator's opinion should preclude participation in study

Where it's running

• Behr Laser & Skin Care Center
  Fresno, California, United States Recruiting
• Aesthetics By Dr. Lee
  Granite Bay, California, United States Recruiting
• Carlo Honrado, MD, FACS
  Los Angeles, California, United States Recruiting
• N2 Aesthetics
  Manhattan Beach, California, United States Recruiting
• Marina Plastic Surgery
  Marina del Rey, California, United States Recruiting
• Ziering Medical
  West Hollywood, California, United States Recruiting

Study contacts

• Study coordinator: Lisa Campbell, PhD
• Email: lisa.campbell@acorn.me
• Phone: 858-997-7447

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 0.5% Timolol drops versus IPL for treating red marks left by acne (post‑inflammatory erythema)

  This will test whether applying 0.5% timolol eye drops to the skin can reduce the red marks left after acne in people age 12 and older, compared with intense pulsed light (IPL).

  Recruiting Early Phase 1 Pham Ngoc Thach University of Medicine · Ho Chi Minh City · NCT07474883

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.